| Name | AZ7550 hydrochloride |
| Description | AZ7550 hydrochloride (AZ7550 hydrochloride ), an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM). |
| In vitro | AZ7550 (Compound 28) inhibits double mutant (DM) cell line H1975, activating mutant (AM) cell line PC9, and wild type (WT) cell line LoVo (IC50s: 45, 26, and 786 nM). AZ7550 inhibits DM antiproliferative cell line H1975, AM antiproliferative cell line PC9, and WT antiproliferative cell line Calu3 (GI50s: 19, 15, and 537 nM). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 1.5 mg/mL (2.8 mM), Sonication and heating are recommended.
|
| Keywords | Txk | TEC | PYK2 | MNK2 | MLK1 | IRR | Ins R | Inhibitor | inhibit | IGF-1R | IGF1R | HER1 | FLT4 | FLT3 | FES | FAK | ErbB4 | ErbB-1 | Epidermal growth factor receptor | EGFR | Drug Metabolite | BTK | BRK | BLK | AZ-7550 hydrochloride | AZ-7550 Hydrochloride | AZ7550 hydrochloride | AZ7550 Hydrochloride | AZ-7550 | AZ7550 | AZ 7550 Hydrochloride | AZ 7550 | ALK | ACK1 | 1421373-99-0 free base | 1421373-99-0 |
| Inhibitors Related | Melamine | Mycophenolate Mofetil | Osimertinib | Lapatinib | Sorbic acid | Erlotinib | Neratinib | Isonicotinic acid | Urolithin A | Tranexamic acid | Gefitinib | Lansoprazole sulfide |
| Related Compound Libraries | Anti-Lung Cancer Compound Library | Glycometabolism Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Tyrosine Kinase Inhibitor Library | Angiogenesis related Compound Library | Inhibitor Library | Anti-Aging Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Liver Cancer Compound Library |